Health Sciences Group, Inc. HESG OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

27/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Health Sciences Group, Inc. (HESG) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 25/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

27/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

25/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

0/100

→ Income

✓

GROWTH

100/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — HESG

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio5.22

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2000	$-0.02	$0.00	$-34.25K	-
2001	$-0.22	$341.81K	$-735K	-215%
2002	$-0.73	$5.54M	$-4.28M	-77.4%
2003	$-0.76	$5.37M	$-7.42M	-138.3%
2004	$-0.78	$67.2K	$-10.45M	-15552.6%
2005	$-0.25	$60.14K	$-5.75M	-9560.7%
2012	$0.00	$358.43K	$-54.49K	-15.2%